Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Medicine|February 11, 2005
Fish soluble Toll-like receptor 5 (TLR5S) is an acute-phase protein with integral flagellin-recognition activityHironobu Tsukada, Aya Fukui, Tadayuki Tsujita, et al.
The Journal of Biological Chemistry|September 2, 2004
Sensing bacterial flagellin by membrane and soluble orthologs of Toll-like receptor 5 in rainbow trout (Onchorhynchus mikiss)Tadayuki Tsujita, Hironobu Tsukada, Miki Nakao, et al.
Vaccine|November 30, 2005
Fish soluble Toll-like receptor (TLR)5 amplifies human TLR5 response via physical binding to flagellinTadayuki Tsujita, Akihiro Ishii, Hironobu Tsukada, et al.
Pharmacology Research & Perspectives|March 25, 2024
Evaluation of OCT2-mediated drug-drug interactions between ulotaront and metformin in subjects with schizophreniaGuangqing Xiao, Hironobu Tsukada, Yu-Luan Chen, et al.
Neurology and Therapy|March 18, 2023
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in HumansYu-Luan Chen, Hironobu Tsukada, Snezana Milanovic, et al.
Gastroenterology|February 12, 2009
A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis CHironobu Tsukada, Hidenori Ochi, Toshiro Maekawa, et al.
Clinical and Translational Science|March 23, 2023
A randomized, single-dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophreniaHironobu Tsukada, Snezana M Milanovic, Borje Darpo, et al.
Clinical Pharmacokinetics|October 26, 2023
A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy SubjectsHironobu Tsukada, Yu-Luan Chen, Guangqing Xiao, et al.
Pageof 1